Clean ClAImsFirst Pass

Evidently vs Regard

Two Revenue Integrity & Pre-Bill Review vendors, side by side. Facts from public sources; judgments are ours.

At a glance

Derived from public facts · a rough scale, not a ranking

EvidentlyRegard
Pricing model

Enterprise contract (custom) · Pricing not published

Not published · Health system contracts

Speed to go live

SMART on FHIR pilot, then rollout

System-wide EHR embed with chart data access

Automation model

AI copilot · Surfaces evidence, humans decide

AI copilot · diagnosis suggestions inside the chart

Built for

Mid-size groups, Enterprise systems

Enterprise systems

Security posture

SOC 2 Type II, HIPAA

No certifications published

Company maturity

6 yrs (est. 2020)

9 yrs (est. 2017)

Financial backing

$15M · Series A

$80M+ · Series B

Named customers

3 named

4 named

Published results

No public numbers

No public numbers

Documented integrations

4 listed

1 listed

Third-party validation

KLAS / analyst cited

None found

Bottom line

  • Pick Evidently if you want one EHR-embedded chart intelligence layer serving clinicians, CDI, and risk adjustment together.
  • Pick Regard if you run a hospital or health system and want an EHR-embedded copilot that surfaces missed diagnoses and drafts documentation for clinicians.

Evidently

EHR-embedded AI that turns scattered chart data into answers

Founded
2020
HQ
San Francisco, CA
Stage
Series A
Raised
$15M

What it does

  • AI chart summarization inside the EHR
  • Ask Evidently chat pre-loaded with full chart
  • CDI review and denial appeal support
  • HCC capture and care gap reconciliation
  • Note drafting for admits and discharges
  • Registry abstraction and pre-op review

Where it's strong

  • One chart-intelligence layer serves clinicians, CDI teams, and value-based care, spreading cost across use cases.
  • Named academic and health system customers with third-party validation, including a 31.7-point Net EHR Experience Score gain at Iowa measured by KLAS.
  • Allina Health documented 6x ROI on the value-based care use case.

What buyers should weigh

  • Deep EHR embedding means IT involvement and a real pilot; UNC ran 12 weeks before enterprise rollout.
  • It surfaces documentation and HCC opportunities but does not autonomously code or bill.
  • At $15M raised it is a smaller vendor taking on well-funded CDI incumbents.

Named customers

University of Iowa Health Care · Allina Health · UNC Health

Integrations

EpicOracle Health (Cerner)MEDITECHSMART on FHIR
Full Evidently profile →

Regard

AI that surfaces undocumented diagnoses in the workflow

Founded
2017
HQ
Los Angeles, CA
Stage
Series B
Raised
$80M+

What it does

  • Reviews the full patient chart inside the EHR
  • Surfaces missed or undocumented diagnoses to clinicians
  • Drafts clinical notes with supporting evidence linked
  • Runs concurrently during the stay, not post-discharge
  • Improves documentation for both revenue and quality metrics

Where it's strong

  • Works concurrently inside the clinician's Epic workflow, so diagnoses are captured while the physician can still act on them, unlike post-discharge review tools.
  • Multi-year, system-wide proof: Sentara scaled to all 12 hospitals after 2-4x ROI, and Banner rolled it toward 33 hospitals.
  • Cedars-Sinai is investor, development partner, and customer, giving unusual clinical depth for a company this size.

What buyers should weigh

  • Requires physician adoption to deliver value, a harder change-management lift than back-office tools your clinicians never see.
  • Smaller war chest (roughly $80M raised) than several competitors chasing the same documentation dollars.
  • Value proposition mixes clinical decision support with revenue capture; make sure your compliance team is comfortable with how diagnosis suggestions are framed.

Named customers

Cedars-Sinai · Banner Health · Sentara Health · WakeMed Health & Hospitals

Integrations

Epic
Full Regard profile →

Compare against the rest of Revenue Integrity & Pre-Bill Review

Deciding between these two?

First Pass tracks Revenue Integrity & Pre-Bill Review every week: funding, launches, and what changed since this page was written.